Tuberculosis

MEASURE Evaluation achievements in support of the STOP TB Strategy include supporting global standards for tuberculosis monitoring and evaluation; capacity building and technical assistance; development of TB tools and supporting country TB information systems; and evaluation/research.

Tuberculosis (TB) is the leading infectious cause of death and ranks ninth in cause of all deaths worldwide. Although it is curable, each day more than 4,600 people die of TB—as many as 1.7 million deaths each year. And, it is on the move: the latest figures from 2016 show that approximately 104 million people developed TB, including 3.7 million women and one million children. It is the most common cause of death for people with HIV.

TB co-infection with HIV is an issue that makes testing critical for identifying those individuals. In 2015, 35 percent of HIV deaths were due to TB. In Africa, where the burden of HIV-associated TB is the highest, the rate of notified TB patients who also had a documented HIV test result stood at 81 percent, up from only half in 2013. Another issue is that in 2015 almost a half million people globally developed multidrug-resistant TB, yet only 1 in 5 of them were enrolled in treatment.

WHO has a goal for an end to the global TB epidemic by 2035. In order to reach that goal, efforts must be intensified and successes sustained through sufficient funding and access to high-quality data to identify what is working and what interventions are needed. The United States Agency for International Development (USAID) announced in September 2018 a new approach to combat TB: the Global Accelerator to End TB as a new business model for performance-based investments in TB response. As part of that initiative, USAID awarded MEASURE Evaluation an associate award for TB data and systems to accelerate the global response to combat TB. This award—the TB Data, Impact Assessment, and Communications Hub (TB DIAH)—is a five-year program that will be implemented by the University of North Carolina (UNC), which is the prime for MEASURE Evaluation, and John Snow, Incorporated (JSI), one of the five MEASURE Evaluation partners.

MEASURE Evaluation’s strategy for TB DIAH is to provide more accurate and timely data to combat the disease, to share those data widely across all organizations fighting TB, and to establish an information resource repository as a lasting global good. The main objective of TB DIAH is to ensure optimal demand and analysis of TB data, and the appropriate use of such information to measure performance and to inform national TB programs and USAID portfolio interventions and policies. Through the TB DIAH Associate Award, the capacity of TB decision makers to collect, analyze, and use quality information to scale up high-quality and sustainable TB services will be strengthened. TB DIAH will be instrumental in establishing and implementing the performance-based measurement system under the new USAID TB business model. Further, to help determine the impact of TB interventions, MEASURE Evaluation assists to develop monitoring and evaluation standards and tools for national TB program surveillance systems to generate high-quality data for monitoring impact. As data from direct measurements within countries expand and improve, the estimates of TB burden can be refined to better track progress toward meeting the new targets set by WHO.

MEASURE Evaluation also supports USAID’s commitment to the implementation of its STOP TB Strategy to reduce morbidity and mortality associated with TB, and in particular to strengthen TB information systems.

Related Content

Tuberculosis in Nigeria: Rapid Assessment of Infectious Disease Surveillance and Reporting

Evaluating the impact of social support services on tuberculosis treatment default in Ukraine

Strengthening Tuberculosis Control in Ukraine: Evaluation of the Impact of the TB-HIV Integration Strategy on Treatment Outcomes (also available in Ukrainian

Strengthening Tuberculosis Control in Ukraine: Evaluation of the Impact of a Social Support Strategy on Treatment Outcomes

Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs

M&E of Tuberculosis Control Programs Module

The Importance of Gender in Tuberculosis Data

Three Interlinked Patient Monitoring Systems for HIV care/ART, MCH/PMTCT and TB/HIV

Strengthening Tuberculosis Control in Ukraine: Impact Evaluation Baseline Survey, Ukraine 2014 

Infectious Diseases Tools

How does integrating HIV and TB services affect health outcomes for HIV-TB coinfected patients in Ukraine? Results from an impact evaluation

Improving Care for People in Ukraine Who Have Tuberculosis and HIV: Findings from a Qualitative Analysis of Integrated Services

Helping People with Tuberculosis in Ukraine Stay in Treatment – Findings from a Qualitative Analysis of a Social Support Program

Improving Care for People in Ukraine Who Have Tuberculosis and HIV – Findings from a Qualitative Analysis of Integrated Services

Workshop to Disseminate Findings and Facilitate Data Use: Impact Evaluation of Strengthening Tuberculosis Control in Ukraine (STbCU) Project Workshop Report

Filed under: ,